Search Results for "Cosopt"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Cosopt. Results 1 to 4 of 4 total matches.

Brinzolamide/Brimonidine (Simbrinza) for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 2013  (Issue 1421)
) Timolol/dorzolamide – Cosopt (Merck) 0.5%/2% soln* 10 mL 1 drop bid 141.00 generic 60.00 Cosopt PF ...
The FDA has approved Simbrinza (Alcon), an ophthalmic combination of the carbonic anhydrase inhibitor brinzolamide and the selective alpha2-adrenergic receptor agonist brimonidine, for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Simbrinza is the first product to combine drugs from these 2 classes.
Med Lett Drugs Ther. 2013 Jul 22;55(1421):57-8 |  Show IntroductionHide Introduction

Two New Drugs for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Jul 16, 2018  (Issue 1551)
161.00 (Allergan) Timolol/dorzolamide – generic 0.5%/2% soln* 10 mL 1 drop bid 50.00 Cosopt (Merck ...
The FDA has approved two new ophthalmic drugs for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension: latanoprostene bunod (Vyzulta – Bausch and Lomb), a modified prostaglandin analog, and netarsudil (VRhopressa – Aerie), the first Rho kinase inhibitor to be approved in the US.
Med Lett Drugs Ther. 2018 Jul 16;60(1551):117-20 |  Show IntroductionHide Introduction

Drugs for Open-Angle Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Apr 28, 2025  (Issue 1727)
/latanoprost – Rocklatan (Alcon) 0.2%/0.005% soln* 2.5 mL 1 drop qPM 353.60 Timolol/dorzolamide – Cosopt (Thea ...
Glaucoma is a progressive optic neuropathy associated with increased intraocular pressure (IOP; normal range 8-22 mm Hg), which is the only disease-related factor that can be modified. Topical drugs that lower IOP are the first line of treatment for open-angle glaucoma.
Med Lett Drugs Ther. 2025 Apr 28;67(1727):65-8   doi:10.58347/tml.2025.1727a |  Show IntroductionHide Introduction

Drugs for Common Eye Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 02, 2019  (Issue 1586)
– Cosopt (Merck) 0.5%/2% soln* 10 mL 1 drop bid 209.60 generic 50.00 Cosopt PF 0.5%/2% soln 0.2 mL ...
This issue includes reviews of drugs for glaucoma, age-related macular degeneration (AMD), bacterial conjunctivitis, and dry eye disease. Allergic conjunctivitis is reviewed in a separate issue.
Med Lett Drugs Ther. 2019 Dec 2;61(1586):187-94 |  Show IntroductionHide Introduction